Clinical Trial Update: PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update outlines Phase 1/2 studies investigating the roles of PAI-1, tissue plasminogen activator (tPA), and tissue factor pathway inhibitor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding

Drugs mentioned

• PAI-1 (plasminogen activator inhibitor-1)
• TFPI (tissue factor pathway inhibitor)
• tPA (tissue plasminogen activator)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Menstrual Bleeding, Heavy | Phase 1, Phase 2 | Status: RECRUITING